EPA is the omega-3 most consistently recommended for managing high cholesterol, primarily because it lowers triglycerides without raising LDL cholesterol. DHA also lowers triglycerides effectively, but it can push LDL numbers up, which is exactly what most people with cholesterol concerns are trying to avoid. The distinction matters more than most supplement labels suggest.
Why EPA and DHA Affect Cholesterol Differently
EPA and DHA are both long-chain omega-3 fatty acids found in fish oil, but they behave differently once they’re in your body. The key difference comes down to how each one interacts with LDL cholesterol, the type most closely linked to heart disease risk.
EPA has a neutral to slightly beneficial effect on LDL. In clinical studies, pure EPA supplementation either held LDL steady or produced a small reduction compared to placebo. DHA, on the other hand, consistently raises LDL cholesterol, and the effect is more pronounced in men than in women. A systematic review in the National Library of Medicine confirmed that DHA administration resulted in a greater increase in LDL cholesterol compared to EPA across multiple trials.
The mechanism behind this involves how DHA changes the way your liver processes fats. DHA reduces a protein called ApoC3, which speeds up the conversion of very-low-density lipoprotein (VLDL) into LDL particles. So while DHA is clearing triglyceride-rich particles from your blood (a good thing), it’s generating more LDL in the process.
The LDL Particle Size Question
There’s an important nuance here. Not all LDL is equally harmful. Small, dense LDL particles are more likely to damage artery walls than large, buoyant ones. DHA supplementation shifts LDL toward larger particles: one study in overweight adults found that DHA increased large LDL particle concentrations by 40% while decreasing small LDL particles by 18%. It also boosted large HDL (the protective cholesterol) and shrank VLDL particle size.
This means the LDL increase from DHA may not be as dangerous as a standard lipid panel makes it look. However, most doctors still base treatment decisions on total LDL numbers. If your LDL is already elevated or you’re on a statin, an omega-3 that raises LDL creates a practical problem regardless of particle size. That’s why EPA remains the safer choice for most people managing cholesterol.
Both Lower Triglycerides Effectively
Where EPA and DHA agree is triglycerides. Both reliably bring them down, and high triglycerides often travel alongside high cholesterol. The American Heart Association concluded that prescription omega-3s at a dose of 4 grams per day (delivering over 3 grams of combined EPA and DHA) can reduce triglycerides by 30% or more in people with levels at or above 500 mg/dL.
Most people see measurable changes in their lipid panels within about 12 weeks of consistent supplementation at therapeutic doses. Standard over-the-counter fish oil capsules typically contain far less EPA and DHA per pill than what clinical trials use, so reaching effective levels often requires multiple capsules daily or choosing a concentrated formula.
Prescription Omega-3s and What Sets Them Apart
Two prescription omega-3 products illustrate the EPA vs. DHA distinction clearly. Lovaza contains both EPA and DHA (about 465 mg EPA and 375 mg DHA per capsule), while Vascepa contains only purified EPA (1 gram per capsule). Both are FDA-approved to treat severely elevated triglycerides.
In head-to-head comparisons, both products markedly reduced triglycerides. But DHA-containing products like Lovaza increased median LDL cholesterol by up to 49% compared to placebo in some studies of patients with high triglycerides. Vascepa showed no significant LDL increase, and in certain trials demonstrated a small but significant LDL reduction.
The most compelling evidence for EPA came from the REDUCE-IT trial, published in the New England Journal of Medicine. Over 8,000 patients on statins with elevated triglycerides took either 4 grams daily of purified EPA or placebo. The EPA group had a 25% lower rate of major cardiovascular events, including heart attack, stroke, and cardiovascular death. That’s one of the largest risk reductions ever seen with a lipid-lowering add-on therapy.
What About Fish Oil Supplements?
Most fish oil capsules at the drugstore contain a mix of EPA and DHA, typically in a roughly 60/40 or 50/50 ratio. A standard 1,000 mg fish oil capsule delivers only about 300 mg of combined EPA and DHA. The rest is other fats. To reach the 3+ grams of EPA and DHA used in clinical trials, you’d need 10 or more standard capsules per day.
Concentrated fish oil products are available that pack 600 to 900 mg of omega-3s per capsule, and some are formulated to emphasize EPA over DHA. If your goal is cholesterol management, look for a supplement with a high EPA-to-DHA ratio and check the “Supplement Facts” panel for the actual EPA and DHA content, not just total fish oil. The form of the omega-3 (triglyceride form vs. ethyl ester) has been debated, but a randomized crossover trial found no significant difference in absorption between the two.
Algal oil supplements are another option, though most algal products are DHA-dominant. A few newer formulations offer EPA from algae, but they’re less common and often more expensive.
Safety at Higher Doses
Omega-3s are well tolerated at moderate doses, but high-dose supplementation carries a specific risk worth knowing about. A review of data from over 81,000 patients across seven clinical trials found that people taking more than 1 gram per day of omega-3 fatty acids had a 49% increased risk of developing atrial fibrillation, an irregular heart rhythm. Those taking 1 gram or less had only a 12% increased risk.
This doesn’t mean everyone on high-dose omega-3s will develop heart rhythm problems, but it’s a real signal that becomes relevant at the therapeutic doses used for triglyceride and cholesterol management. If you’re considering doses above 1 gram per day, that’s a conversation to have with your doctor, especially if you have any history of irregular heartbeat.
Choosing the Right Omega-3 for Your Situation
If your main concern is elevated LDL cholesterol, EPA-dominant supplements or pure EPA formulations are the strongest choice. They won’t push your LDL higher and may modestly lower it. If your triglycerides are also elevated, EPA still handles that effectively.
DHA isn’t a bad fat. It plays critical roles in brain health and has cardiovascular benefits of its own, including raising HDL and shifting LDL particles to a less harmful size. For someone whose LDL is well controlled but who wants broad cardiovascular and cognitive support, a combined EPA/DHA product is reasonable.
But for the specific goal of improving a cholesterol panel, particularly when LDL is the number your doctor is watching, EPA is the omega-3 with the cleanest track record. It lowers triglycerides, leaves LDL alone or nudges it down, and has the strongest clinical trial evidence linking it to fewer heart attacks and strokes.